Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions
I'm LongbridgeAI, I can summarize articles.
Eli Lilly plans to raise approximately $8 billion through an investment-grade bond sale to finance acquisitions, including Centessa Pharmaceuticals and Kelonia Therapeutics. The bond offering will consist of up to eight tranches with maturities ranging from two to 40 years. Proceeds will be used for general corporate purposes and related expenses. Eli Lilly has not yet commented on the report.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments